Top 10 Companies in the Highly Branched Cyclic Dextrin (HBCD) Market (2026): Market Leaders Driving Global Adoption

MARKET INSIGHTS

Global Highly Branched Cyclic Dextrin (HBCD) market size was valued at USD 16.94 million in 2025. The market is projected to grow from USD 18.47 million in 2026 to USD 30.78 million by 2034, exhibiting a Compound Annual Growth Rate (CAGR) of 9.1% during the forecast period. In terms of volume, global sales reached approximately 1,867 tons in 2024, with an average price of USD 6,757 per ton.

Highly Branched Cyclic Dextrin (HBCD) is a novel type of enzymatically modified dextrin produced from waxy corn starch (amylopectin). The manufacturing process involves a specific branching enzyme that facilitates a cyclization reaction, creating a unique structure of high‑molecular‑weight, highly branched cyclic clusters. This architecture imparts critical functional properties, including very low osmolality, high solubility, and rapid gastric emptying. These characteristics make HBCD particularly valuable for delivering large carbohydrate doses with minimal gastrointestinal distress, a significant advantage in sports nutrition.

The market growth is driven by rising demand in sports supplements, where its performance benefits are highly sought after. Furthermore, the ingredient’s FDA GRAS (Generally Recognized as Safe) status, secured by pioneers like Glico Nutrition in 2012, allows its use as a carbohydrate source and flavor carrier in various food and beverage categories. The industry is notably concentrated, with Glico Nutrition and ZymeBase being the key technology holders, and features a typical gross margin range of 28% to 30%. The United States, Japan, and China are the primary consumption regions, with China showing the greatest market potential as its domestic output increases.

Highly Branched Cyclic Dextrin (HBCD) Market – View in Detailed Research Report

Top 10 Companies in the HBCD Market

1. Glico Nutrition (Japan)

Headquarters: Osaka, Japan
Key Offering: Commercial production of HBCD, advanced carbohydrate solutions for sports nutrition and functional foods

Glico Nutrition pioneered the commercial production of HBCD in 2012, establishing a robust pipeline of high‑quality, low‑osmolality carbohydrate ingredients. The company’s proprietary branching enzyme platform and extensive safety dossier underpin its GRAS status, giving it a decisive advantage in markets that demand stringent regulatory compliance.

Sustainability & Growth Initiatives:

• Investment in non‑GMO waxy corn sourcing to meet clean‑label demands
• Expansion of R&D capabilities to develop HBCD derivatives for pharmaceutical applications
• Strategic partnerships with leading sports nutrition brands to accelerate market penetration

2. ZymeBase (China)

Headquarters: Shanghai, China
Key Offering: Proprietary HBCD platform (SusCarb® Dextrin) and tailored carbohydrate solutions for food, beverage, and nutraceutical markets

ZymeBase has carved out a niche by leveraging its patented enzymatic process to produce HBCD with a high degree of customization. The company’s focus on scalable production and regional supply chain optimization has positioned it as a key player in the rapidly growing Chinese market.

Sustainability & Growth Initiatives:

• Development of eco‑friendly fermentation processes to reduce carbon footprint
• Collaboration with local universities to advance enzymatic technology
• Targeted marketing campaigns emphasizing natural ingredient profiles

3. DuPont Nutrition & Biosciences (USA)

Headquarters: Wilmington, Delaware, USA
Key Offering: Advanced carbohydrate ingredients for sports nutrition and functional foods

DuPont’s extensive portfolio of carbohydrate solutions and its expertise in enzymatic synthesis make it a credible contender in the HBCD space. While not a primary HBCD producer, its research pipeline includes high‑molecular‑weight dextrins that share functional attributes with HBCD.

Sustainability & Growth Initiatives:

• Investment in sustainable sourcing of raw materials
• Partnerships with nutrition scientists to validate performance claims
• Expansion of global distribution networks to support emerging markets

4. Kemin Industries (USA)

Headquarters: St. Joseph, Missouri, USA
Key Offering: Specialty carbohydrate ingredients for food and beverage applications

Kemin’s focus on functional ingredient development aligns with the demand for clean‑label, high‑performance carbohydrates. The company is exploring the potential of HBCD‑style molecules to enhance product stability and consumer experience.

Sustainability & Growth Initiatives:

• Development of low‑energy manufacturing processes
• Commitment to reducing waste in the production cycle
• Strategic alliances with health‑conscious food brands

5. Ingredion (USA)

Headquarters: Dublin, Ohio, USA
Key Offering: Carbohydrate solutions for food, beverage, and pharmaceutical sectors

Ingredion’s extensive experience in starch modification positions it to evaluate HBCD’s potential in new applications, particularly in nutraceutical formulations where controlled digestion is critical.

Sustainability & Growth Initiatives:

• Investment in renewable feedstock sourcing
• Research into enzyme‑driven carbon‑neutral processes
• Expansion of product lines to meet clean‑label consumer preferences

6. Cargill (USA)

Headquarters: Minnetonka, Minnesota, USA
Key Offering: Advanced carbohydrate ingredients and processing technologies

Cargill’s global reach and strong R&D capabilities provide a platform to explore HBCD’s integration into large‑scale food manufacturing.

Sustainability & Growth Initiatives:

• Focus on responsible sourcing of agricultural raw materials
• Development of low‑emission production facilities
• Partnerships with food manufacturers to create high‑performance, low‑GI products

7. DSM (Netherlands)

Headquarters: Heerlen, Netherlands
Key Offering: Functional ingredients for nutrition and health markets

DSM’s expertise in enzymatic processes and nutritional science makes it a strategic player when assessing HBCD’s potential in specialty nutrition products.

Sustainability & Growth Initiatives:

• Commitment to circular economy principles in ingredient development
• Investment in enzyme technology to enhance yield and reduce waste
• Collaboration with health‑tech startups to broaden application scope

8. BASF (Germany)

Headquarters: Ludwigshafen, Germany
Key Offering: Innovative carbohydrate and functional ingredient solutions

BASF’s chemical and biotechnological capabilities provide a foundation for exploring advanced carbohydrate structures similar to HBCD.

Sustainability & Growth Initiatives:

• Development of bio‑based fermentation platforms
• Focus on energy‑efficient production processes
• Strategic alliances with European food and pharma companies

9. Tate & Lyle (UK)

Headquarters: London, United Kingdom
Key Offering: Specialty sweeteners and carbohydrate ingredients for food and beverage

Tate & Lyle’s portfolio of carbohydrate derivatives positions it to evaluate HBCD’s potential in high‑end, low‑GI product lines.

Sustainability & Growth Initiatives:

• Investment in sustainable sourcing of starches
• Development of low‑energy processing techniques
• Partnerships with premium food brands to showcase functional ingredients

10. Nutrient Sciences (USA)

Headquarters: Los Angeles, California, USA
Key Offering: Nutritional supplements and functional ingredients for sports and wellness markets

Nutrient Sciences is exploring the integration of high‑molecular‑weight carbohydrate structures, such as HBCD, to enhance product performance for athletes and health‑conscious consumers.

Sustainability & Growth Initiatives:

• Focus on clean‑label ingredient sourcing
• Research into rapid‑release carbohydrate formulations
• Collaboration with sports nutrition brands to drive adoption

Highly Branched Cyclic Dextrin (HBCD) Market – View in Detailed Research Report

Highly Branched Cyclic Dextrin (HBCD) Market – View in Detailed Research Report

Market Outlook

The HBCD market is positioned for steady expansion, driven by the increasing need for clean‑label, high‑performance carbohydrate ingredients in sports nutrition, functional foods, and pharmaceutical excipients. The concentration of technology holders underscores the premium nature of the product, while regulatory clarity through GRAS notifications supports wider adoption across North America, Europe, and Asia. However, the higher production costs and complex enzymatic processes remain a barrier for new entrants, reinforcing the current market structure.

Future Trends

• Personalized nutrition: Demand for tailored carbohydrate profiles will push HBCD developers to create variants optimized for specific athlete groups or metabolic conditions.
• Expansion into cosmetics: The high solubility and carrier properties of HBCD open opportunities for stable delivery of active ingredients in skincare and haircare formulations.
• Pharmaceutical excipient applications: HBCD’s ability to improve drug solubility and bioavailability will drive its use in targeted drug delivery systems.
• Emerging market penetration: Rapid growth in Asia‑Pacific and Latin America, fueled by rising disposable incomes and health consciousness, will broaden the addressable market for HBCD.
• Technological innovation: Continuous refinement of branching enzyme catalysts and process scalability will reduce production costs, potentially broadening market share.